SynthesisNeurosurgical review2026
Long-term hearing and facial nerve outcomes after hearing preservation surgery for vestibular schwannoma: a systematic review and meta-analysis.
Synthesis in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hearing preservation remains a key goal in the management of vestibular schwannoma. Here, we aimed to evaluate long-term hearing and facial nerve outcomes following hearing preservation surgery for VS. A systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed and Embase were searched for studies reporting long-term hearing outcomes after VS resection via the retrosigmoid or middle fossa approach. Studies with at least a 5-year follow-up were included. The primary outcome was long-term serviceable hearing, defined as American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Class A or B. The secondary outcome was long-term preservation of facial nerve function, defined as House-Brackmann Grade I. Of the 1806 studies screened, a total of 8 studies reporting 310 patients with long-term hearing outcomes and 228 patients with facial nerve outcomes were included in the meta-analysis. The pooled proportion of patients with long-term serviceable hearing was 60% (95% CI: 52%-68%), with no significant difference between the retrosigmoid (57%) and middle fossa (60%) approaches (p = 0.63). Facial nerve function was well preserved, with 94% (95% CI: 72%-99%) of patients achieving House-Brackmann Grade I facial nerve function at long-term follow-up. No significant difference was observed between the two surgical approaches in terms of facial nerve function preservation (p = 1.000). In conclusion, long-term preservation of hearing function is feasible in the surgical management of VS and is associated with excellent facial nerve outcomes, with comparable outcomes observed between the retrosigmoid and middle fossa surgical approaches.
Indexed as
Identifiers
41484281What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.